cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Abd. Kakhar Umar
Contact Email
abdulkaharumar@gmail.com
Phone
+6282216335184
Journal Mail Official
sciphar@etflin.com
Editorial Address
Sungai Manonda Street, Syukur Aisle No. 2, RT 004/ RW 001, Duyu Village, Tatanga District
Location
Kota palu,
Sulawesi tengah
INDONESIA
Sciences of Pharmacy
Published by ETFLIN
ISSN : 28307046     EISSN : 28307259     DOI : https://doi.org/10.58920/sciphar
Core Subject : Health, Science, Engineering,
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Health Professions Medicine & Pharmacology Public Health
Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. Every year, we hold seminars/webinars under the ETFLIN Scientific Society to facilitate the exchange of information concerning pharmacist research progress. Publication on SciPhar is free of charge at any stage. Scope We are accepting articles related to drug development (preclinical and clinical drug development, drug delivery, and pharmaceutical formulation). Fundamental and clinical pharmacology (drug mechanisms, pharmacokinetics, pharmacodynamics, drug metabolism, and pharmacogenetics). Pharmaceuticals (gene-based, cell-based, protein-based therapy, other drug modalities, routes of administration, drug classes, drug nomenclature). Drug toxicity and safety (drug-drug interactions, adverse drug reactions, mechanisms of drug toxicity, pharmacovigilance). Pharmacoepidemiology, pharmacoeconomics, and pharmacy.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Pharmacology, Toxicology and Pharmaceutics (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Volume 2 Issue 1" : 5 Documents clear
Hypertriglyceridemia Induced Acute Pancreatitis: A Learn from New Cases
Sciences of Pharmacy Volume 2 Issue 1
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar02010001

Abstract

An increased risk of morbidity and mortality is associated with acute pancreatitis (AP) brought on by hypertriglyceridemia (HTG). It is essential to locate the root cause as soon as possible and give those affected the attention they need. The treatment plan includes efforts to lower blood triglyceride levels and supportive care. HTG-induced AP has a similar clinical course to people with other types of acute pancreatitis. However, HTG-induced AP patients have significantly higher clinical severity and associated consequences. As a result, therapy and preventing sickness recurrence depend on a correct diagnosis. At the moment, there are no acknowledged standards for the treatment of HTG-induced AP. Some therapy approaches that effectively decrease serum triglycerides include fibric acids, apheresis/plasmapheresis, insulin, heparin, and omega-3 fatty acids. Following acute phase care, lifestyle modifications, including dietary and drug therapy, are essential for long-term HTG-induced AP control and relapse prevention. To create complete and efficient HTG-induced AP treatment guidelines, more study is required.
Randomized Open Clinical Trial to Evaluate Netratarpana Efficacy in Elderly Patients with Primary Insomnia (Anidra)
Sciences of Pharmacy Volume 2 Issue 1
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar02010014

Abstract

Primary insomnia is the most prevalent health problem among the elderly in India. It is linked to musculoskeletal disorders, cardiac disorders, Chronic Obstructive Pulmonary Disease (COPD), depression, and schizophrenia. The incidence rate of primary insomnia among the elderly is 5%, and the prevalence rate is 20% or more. With an increase in the geriatric population, this prevalence rate will increase further. In Ayurveda, Netratarpana is described as a treatment modality for insomnia, but it was not studied yet. The study aimed to evaluate the efficacy of Netratarpana in Anidra (primary insomnia). In this RCT, 70 patients with Primary insomnia were randomly divided into two groups. In group A (n=35), Netratarpana was performed for 14 days, and group B (n= 35) was given Jatamansi powder 5 g at night with buffalo milk for 14 days as a comparison. The follow-up was taken on the 7th, 14th, and 21st day. The assessment was done using the Insomnia Severity Index (ISI) with the addition of Ayurvedic parameters. A total of 49 (70%) patients have an average age of 59.3 ± 3 years. There were 50 (71.4%) males and 20 (28.6 %) females. The sleep pattern was disturbed among 7 (10%), delayed among 19 (27.1%), and disturbed and delayed among 44 (62.9%). We found both Netratarpana and Jatamansi powder are effective in inducing sleep and preventing awakening during the night with a p-value of <0.05. It can be concluded that Netratarpana is effective in managing Anidra (primary insomnia), but the stability of the results needs to be confirmed by further study.
Antihyperlipidemic and Antioxidant Activities of Ethanolic Extract of Paederia foetida Leaves (EEPFL) in Albino Rats
Sciences of Pharmacy Volume 2 Issue 1
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar02010022

Abstract

The present study was designed to evaluate the antihyperlipidemic and antioxidant activities of leaves of Paederia foetida (EEPFL). The ethanolic extract was obtained by infusion method, and acute oral toxicity tests were performed according to Organization for Economic Cooperation and Development, 2006 (OECD) guidelines. Hyperlipidemia was induced by feeding the rats with a high-fat diet consisting of coconut oil and vanaspati ghee in a ratio of 2:3 v/v at a dose of 10 ml/kg body weight. The extract was given at a dose of 500mg/kg body weight. Total cholesterol, triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol were measured for antihyperlipidemic activity. For antioxidant activity, Malondialdehyde (MDA), Catalase (CAT), and Superoxide Dismutase (SOD) were measured using standard methods. The extract showed a significant decrease in total cholesterol, triglycerides, LDL, and MDA in the blood. On the other hand, HDL, CAT, and SOD increased significantly. The study demonstrated that the ethanolic extract of leaves of Paederia foetida decreased blood lipid levels and lipid peroxidation. These findings suggest that the EEPFL may have potential therapeutic applications in the treatment of hyperlipidemia and oxidative stress-related diseases.
Novasome: Combining Ufasome and Niosome for Excellent Vesicular Drug Delivery System
Sciences of Pharmacy Volume 2 Issue 1
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar02010035

Abstract

Novasome technology is a novel encapsulation-based drug delivery method that is more effective and efficient than standard liposome systems. It is composed of a mixture of surfactant, cholesterol, and free fatty acids, which produce superior vesicle characteristics for drug delivery. Various studies have investigated the optimal combination of surfactant type, free fatty acid type, and their ratio, as well as the formulation factors that can significantly affect the vesicle characteristics. The novasome technology has demonstrated its potential for delivering a range of substances, including terconazole, fenticonazole, zolmitriptan, and vaccines. Novasomes can be produced using various methods, such as the thin film hydration (TFH) method, injection method, and vortex method combined with a suitable size reduction method. Future research can focus on exploring the potential of novasome technology for delivering a wider range of drugs and vaccines and developing more efficient and effective methods for producing novasome vesicles.
Penicillin Binding Protein Mutation and Beyond: A Comprehensive Approach to Addressing Streptococcus pneumoniae Resistance
Sciences of Pharmacy Volume 2 Issue 1
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar02010050

Abstract

Antibiotic resistance is a critical issue that threatens global health. Streptococcus pneumoniae, a common respiratory pathogen, has developed resistance to β-lactam antibiotics, which is of great concern. The primary mechanism of β-lactam resistance in S. pneumoniae is the acquisition of PBP genes from related species through recombination, resulting in changes in penicillin-binding proteins that affect cell wall synthesis. This mini-review summarized the understanding of β-lactam resistance in S. pneumoniae, focusing on the mechanisms and factors influencing resistance development. We conducted a comprehensive literature search using PubMed and Google Scholar, with the keywords ‘Resistant Streptococcus pneumonia’, ‘Mechanism of Streptococcus pneumoniae resistant’, and ‘Penicillin Resistant on Binding Protein of Streptococcus pneumonia’. Our literature review revealed that the prevalence of β-lactam resistance in S. pneumoniae has increased, leading to treatment failures and mortality rates. In addition to acquiring PBP genes, mutations in other PBP and non-PBP genes can contribute to resistance. Furthermore, S. pneumoniae has intrinsic resistance to various antibiotics, including first-generation polypeptides, aminoglycosides, and quinolones. Our review highlights the importance of understanding the complex mechanisms of β-lactam resistance and the need for continued efforts to monitor and control antibiotic resistance in S. pneumoniae. Further research is needed to explore novel strategies for combating antibiotic resistance in this pathogen.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Volume 5 Issue 1 Volume 4 Issue 4 Volume 4 Issue 3 Volume 4 Issue 2 Volume 4 Issue 1 Volume 3 Issue 4 Volume 3 Issue 3 Volume 3 Issue 2 Volume 3 Issue 1 Volume 2 Issue 4 Volume 2 Issue 3 Volume 2 Issue 2 Volume 2 Issue 1 Volume 1 More Issue